Clopidogrel-MP Endo Derivative 13CD3
| Product Name | Clopidogrel-MP Endo Derivative 13CD3 |
|---|---|
| Alternate Names | Clopidogrel Stable Isotopes, Stable Isotopes of Clopidogrel |
| CAT No. | CS-T-51224 |
| CAS No. | 1346597-76-9 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 508.01 g/mol |
| Mol. For. | C₂₄¹³CH₂₃D₃ClNO₆S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Clopidogrel |
| Canonical Smiles | COC1=CC=CC(=C1)C(=O)CSC2=C(CN(CC2)C(C3=CC=CC=C3Cl)C(=O)OC)CC(=O)O |
| InchIKey | BNGUEGYOTLVBPU-KQORAOOSSA-N |
| Inchl | InChI=1S/C25H26ClNO6S/c1-32-18-7-5-6-16(12-18)21(28)15-34-22-10-11-27(14-17(22)13-23(29)30)24(25(31)33-2)19-8-3-4-9-20(19)26/h3-9,12,24H,10-11,13-15H2,1-2H3,(H,29,30)/i1+1D3 |
| IUPAC | 2-[1-[1-(2-chlorophenyl)-2-methoxy-2-oxoethyl]-4-[2-oxo-2-[3-(trideuterio(113C)methoxy)phenyl]ethyl]sulfanyl-3,6-dihydro-2H-pyridin-5-yl]acetic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Clopidogrel-MP Endo Derivative 13CD3 is a medication used to prevent blood clots and reduce the risk of heart attack and stroke. This drug works by inhibiting platelet activation and aggregation, which are crucial steps in the formation of blood clots. Clopidogrel-MP Endo Derivative 13CD3 is a modified version of clopidogrel, which is a widely used antiplatelet medication. The modification involves the incorporation of deuterium, a stable isotope of hydrogen, into the molecule. This modification enhances the drug's efficacy and duration of action by slowing down its metabolism and increasing its bioavailability.
Clopidogrel-MP Endo Derivative 13CD3 is administered orally and is rapidly absorbed into the bloodstream. The drug is extensively metabolized in the liver and excreted in the urine and feces. The recommended dosage for clopidogrel-MP Endo derivative 13CD3 varies depending on the patient's medical condition and other factors. It is essential to follow the prescribed dosage and consult a healthcare provider before adjusting the dosage or stopping the medication.
There are some potential side effects associated with clopidogrel-MP Endo derivative 13CD3, including bleeding, bruising, and gastrointestinal discomfort. Patients should inform their healthcare provider if they experience any unusual symptoms while taking this medication.
In conclusion, clopidogrel-MP Endo derivative 13CD3 is a modified version of clopidogrel that is used to prevent blood clots and reduce the risk of heart attack and stroke. The drug's modification enhances its efficacy and duration of action, making it a highly effective antiplatelet medication. Patients should follow the prescribed dosage and consult a healthcare provider if they experience any unusual symptoms while taking this medication.
Get an Instant Quote
Related Compounds
Clopidogrel Amide-d4 | Clopidogrel carboxylic acid, racemic mixture 13C6 | Clopidogrel D3 hydrochloride | Clopidogrel-13CD4 Thiol Metabolite | Clopidogrel D3 Hydrogen sulphate | Clopidogrel 13C D4 Hydrochloride | cis-Clopidogrel-MP-13C,d3 Derivative | Clopidogrelat-13C-d4 | Clopidogrel hydrogensulfate 13C6 | trans-Clopidogrel-MP-13C,d3 Ethyl Ester Derivative (Mixture of Diastereomers) | Clopidogrel carboxylic acid D4 | Clopidogrel 13CD3 | trans-Clopidogrel-d3 Thiol Metabolite (Mixture of Diastereomers) | rac-Clopidogrel-d3 Bisulfate | Clopidogrel Carboxylic acid D4 Hydrochloride | rac Clopidogrel-d8 Hydrogen Sulfate (Major) | Clopidogrel-D4 Hydrogensulfate | Clopidogrel 13CD3 Hydrogen Sulfate |